Self-assembling peptide scaffolds for bone tissue engineering
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current bone grafts face challenges such as donor-site morbidity, infection, immune rejection, and limited mechanical strength, while existing hydrogels for bone tissue engineering lack sufficient mechanical properties and safety for clinical use.
Innovation Solution
A 3-dimensional osteo-tissue graft comprising live mesenchymal stem cells and ultrashort self-assembling peptide scaffolds, which can be printed using a 3D bioprinter and cultured in osteogenic induction media to support osteogenic differentiation and angiogenesis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional bone grafts (autografts, allografts, xenografts) are used, then bone defect repair is achieved, but donor-site morbidity, infection, immune rejection, and pain occur
Solution Approach 1:
The patent uses the patient's own bone marrow mesenchymal stem cells (autologous cells) to generate bone tissue, eliminating the need for donor sites and reducing immune rejection risks. The cells are harvested from the patient, expanded in culture, and returned to form bone at the defect site, making the system self-service and avoiding external graft complications
Solution Approach 2:
The patent transforms the physical state and organizational structure of stem cells from a single-cell suspension to a three-dimensional tissue construct with specific architectural parameters. By controlling cell density, scaffold structure, and culture conditions, the system optimizes bone formation while eliminating the harmful effects associated with traditional grafting methods
2Reliability
If collagen matrices are used as scaffolds, then biocompatibility and low antigenicity are achieved, but mechanical strength is insufficient and degradation is quick
Solution Approach 1:
The patent creates a composite tissue construct combining living bone marrow mesenchymal stem cells with a three-dimensional scaffold structure. The scaffold provides mechanical support while the living cells contribute to tissue strength through matrix production and cellular activity, creating a composite material system that overcomes the limitations of pure collagen matrices
Solution Approach 2:
The patent modifies the physical parameters of the scaffold by creating a three-dimensional structure with controlled porosity, surface area, and mechanical properties. This structural transformation allows the scaffold to provide adequate mechanical strength while maintaining biocompatibility and supporting cell growth
3Productivity
If 2D cell culture is used, then cell proliferation is achieved, but osteogenic differentiation and bone formation are limited
Solution Approach 1:
The patent transitions from two-dimensional cell culture to three-dimensional tissue construction by organizing bone marrow mesenchymal stem cells into a three-dimensional scaffold structure. This dimensional change provides enhanced cell-cell and cell-matrix interactions, promoting osteogenic differentiation and bone formation while maintaining cell proliferation capabilities
Solution Approach 2:
The patent creates localized microenvironments within the three-dimensional construct that provide specific conditions for osteogenic differentiation. The scaffold structure creates regions with appropriate mechanical properties, nutrient diffusion characteristics, and cell-density gradients that locally promote bone formation while maintaining overall system productivity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The peptide hydrogels provide a biocompatible, mechanically robust environment for cell growth and differentiation, enhancing osteogenic differentiation and angiogenesis, and can be tuned for varying mechanical stiffness to support bone regeneration.
Implementation Method 1
ultrashort self-assembling peptide scaffolds
Data Source
AI summary
The present disclosure relates generally to an osteo-tissue graft capable of promoting bone tissue growth and regeneration, comprising at least one self-assemble peptide and mesenchymal stem cells (MSCs) in accordance with the present invention and a method of preparing such an osteo-tissue graft. The grafts are suitable for treatment of bone disorder or damages through tissue engineering, cellular replacement therapies as well as other applications.